3

FORM 3 SUBMISSION

Company: KalVista Pharmaceuticals, Inc.
Filed: August 5, 2015
Period of Report: July 1, 2015
Accession Number: 0000899243-15-002405

View Document ↗ View on SEC.gov ↗